A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
about
A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapyVaginal rejuvenation using energy-based devicesMicroscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment.Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.Treatment of the genitourinary syndrome of menopause.Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.An update on drugs for the treatment of menopausal symptoms.Computer simulations of thermal tissue remodeling during transvaginal and transurethral laser treatment of female stress urinary incontinence.Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopauseThe effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women.Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.Optical clearing of vaginal tissues, ex vivo, for minimally invasive laser treatment of female stress urinary incontinence.Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women.Monurelle Biogel(®) vaginal gel in the treatment of vaginal dryness in postmenopausal women.Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause.Management of Potential Long-Term Toxicities in Breast Cancer Patients.Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.Nonsurgical Vulvovaginal Rejuvenation With Radiofrequency and Laser Devices: A Literature Review and Comprehensive Update for Aesthetic Surgeons.A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients.The evidence for laser treatments to the vulvo-vagina: Making sure we do not repeat past mistakes.Vaginal hyperlaxity syndrome: a new concept and challenge.Turning the spotlight on lasers.Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO2 Laser Treatment.Erbium laser in gynecology: aims, aspirations and action points.Comments on Singh et al.: Laser vaginal rejuvenation: not ready for prime time.A Dermatologist's Approach to Genitourinary Syndrome of Menopause.Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms.
P2860
Q33605919-793B9208-4583-4F3C-A28A-1B98CA581CF9Q33641124-EEC26DF5-00D0-4908-96B3-184E2CCD1024Q35437729-24DBA997-A2AB-4BA5-B07C-A46B76B52B87Q35647630-6691D3B7-CFFC-48A8-B816-D6DFD8A1926EQ35772318-83978446-55BC-448F-A95C-C424A6356DBBQ35772337-157E411E-2796-4FA4-85EB-4E65E72E696EQ35784054-26E5CB4C-FD92-4BA5-9883-C9C136D06351Q35930120-B1A51F46-540D-43CC-BAB7-EA2D112E22D9Q36015161-A0F54940-AF1B-42B6-AD32-5A26E068063BQ36108656-4FD49CDC-00F2-48F3-A54A-12D51328C0D6Q36112290-5AEBB007-FA62-42D4-91C1-D08372B591A5Q36268498-4DC8CDD8-B92E-4E16-92CC-C633E6623E31Q36285936-2F2A1D89-77F4-4397-8E48-F218BA1727B8Q36310940-5790CE46-C1C2-4B84-8622-8EF76BAC75BEQ36371627-C30DF537-E48D-42D8-B643-F42D8F482024Q38374840-7AC3CF1A-5CEB-4CF6-AF42-655D426E73CCQ38836000-D211FDEB-52A6-41C4-9216-74C39F145B21Q39305824-3B231B07-C006-4C99-A8D7-62126C0B73B5Q40108790-60718FFC-B65A-4321-8D92-1E1AE6AEFE14Q47549545-30CC1EE0-C649-4A0E-B24D-9797E2FF19FCQ47607119-3551C6FA-98F2-4E4F-983E-2F43763EEEACQ47670995-A4C616FE-85D0-4709-AC00-239BFF9C70BBQ47723983-6F26C9AD-DF36-4BB7-92E1-F2555A90F0ABQ48350863-EA6FE825-1B06-4B51-AB92-4FDDFE7AC749Q50237604-CE578E38-A62C-486F-AA4F-ABD827D44690Q50355443-7675BC16-B636-4AFF-9934-B844264A406AQ51721349-F0423FA2-A9D0-42AE-AE9F-C03BD22F91B2Q53280734-AEE269BE-8AC6-49CF-BEEA-4D0501BAA965Q53325328-D897A861-B72A-4513-9964-1E92DA28257CQ53496298-B127FE1B-68E8-4911-B080-E6329A6ECCE1
P2860
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@ast
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@en
type
label
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@ast
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@en
prefLabel
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@ast
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
@en
P2093
P50
P1433
P1476
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study
@en
P2093
A Calligaro
M Candiani
S Salvatore
P304
P356
10.3109/13697137.2014.899347
P577
2014-06-05T00:00:00Z